Back to EZorb Newsletter Index

 

EZorb

  

EZORB MONTHLY NEWSLETTER JAN 28, 2014

In this issue:

 

1. Share Success: Letters From Readers
2. Research News: One In Two Brazilians May Suffer Headache
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?
  

1. Share Success: Letters From Readers 

***************************************************

Letter I: From Jake H., Seattle, WA

Received at Testimonial Submit Form on Friday, December 27, 2013 at 23:25:36

(Unedited)

 

Ezorb Success (please post this on your website)

I recently bought some Ezorb and have only been taking it for 3 days, wow. The pain in my shoulders, knees and neck have almost completely disappeared. This stuff is amazing! One of the best health choices I have ever done and I'm only 40 but I suffer from a knee disease and arthritis in my knees and have had to give up doing martial arts and intensive exercise because of this.

Now I'm thinking about the possibilities of one day accomplishing one of my dreams and that's to go to ninja camp someday. The training is brutal on the knees and body, but I think I'm going to be able to do this one day!

Thanks again for the product and anyone who buys this will see results, believe me, it works!

Jake Hose
Seattle WA


Letter II: From Kenneth M.

Received at info@elixirindustry.com on Friday, September 6, 2013 11:41 AM

(Unedited)

 

To whom it may concern,

My name is ken, and like the 100's of testimonials that influenced my decision to purchase EZORB. I bought my first bottle over two months ago.

I am 48 yrs old, but felt and walked on that right knee like I was 70. I must say that I am a skeptic in every way. Halfway through my first bottle and there are no words to express to you folks at Elixir.

Diagnosed with arthritis with options of knee-replacement or a steroid shot every six months for life? not going to happen. I was a salesman for 5 years and the number one rule is to never sell any thing you don't believe in. Now when I am out in the world and I see that painful walk a person has, I cant help but ask them " do you have arthritis" and when they say yes, My five minute EZORB pitch and testimonial comes out automatically.

This product needs to get out there, those senior citizens at those homes and everyone else, needs to be shown this. This product could put companies out of business. I would gladly do presentations of this product. I cant say enough about EZORB and I am only on my second bottle! I could go on and on.

I would love to sell and get this out there, but if that's not what the goal is at Elixir, I understand, regardless, I will still refer people to your site.

From one extremely happy customer for LIFE!


Letter III: From Dorothy B.

  

Received at ezorb @ ezorbonline.com on Saturday, March 16, 2013 10:51 AM

(Unedited)

 

Hello,

I thought I would let you know -- my bone spur must be disappearing-- It doesn't bother me at all.

I have recommended EZorb to several of my friends, some of them are going to get it.

Thank you
Dorothy

***************************************************

From the Desk of EZorb Newsletter Editor:

 
This newsletter is now read by over 70,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to sharesuccess @ elixirindustry.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public.


2. Research News: One In Two Brazilians May Suffer Headache

 

Headache and orofacial pain have a surprisingly high prevalence in the general Brazilian population, affecting more than half of 890 people interviewed in a study.

Of concern, people with headache and orofacial pain typically also reported chronic comorbidities, reduced general wellbeing, and need for medication.

"The aetiological factors associated with these findings need further investigation to establish the needs of assessment and treatment," write Silvia Regina de Siqueira (University of Sao Paulo, Brazil) and colleagues, who conducted the research.

The team used a population-based cross-sectional design to investigate the epidemiologic characteristics of headache and orofacial pain in Brazilian adults living in Sao Paulo. A total of 505 people aged 18-59 years ("adults") and 385 people aged 60 years and over ("elders") were interviewed using a validated questionnaire.

The overall prevalence of any head and facial pain within the past 6 months was 55.5% (45.3% of adults and 56.6% of elders). The most common complaint was headache (41.1%), followed by bruxism (10.6%), toothache (10.2%), and facial pain (7.7%).

Within the subset reporting pain, 48.6% of adults and 58.7% of elders said they experienced impairments in daily activities due to their pain.

Pain was significantly more prevalent in women than in men. The prevalence of pain was significantly associated with comorbidities (namely, hypertension, diabetes, back pain, chronic nephropathy, depression, osteoporosis, heart disease, chronic pulmonary disease, and chronic digestive disease) and with the use of medications (namely, any chronic medication, analgesics, and anti-inflammatories).

Finally, people with pain reported experiencing significantly poorer general health and less satisfaction with their daily activities, and tended to have a lower overall quality of life than those without pain.

Taken together, these findings suggest that head and orofacial pain are common in the general Brazilian population and have a detrimental impact on people's quality of life.

"In this population, there were multiple complaints such as fatigue, difficulty in mouth opening and bruxism that can be associated with musculoskeletal conditions [such] as [temporomandibular disorders]," remark de Siqueira et al in Gerodontology. "Thus, it is possible that this could be one of the main diagnoses in this sample."

Original research was published in Gerodontology 2013.


3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

  

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ elixirindustry.com for a copy of the instructions.

 

 

5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index

 
 
 
  Copyright 2014 Elixir Industry